Anixa Biosciences, Inc. (ANIX)

Anixa Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is November - October.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 9, 2026	Oct 31, 2024	Oct 31, 2023	Oct 31, 2022	Oct 31, 2021	Oct 31, 2020
Market Capitalization	114	113	98	172	143	49
Market Cap Growth	31.90%	14.71%	-42.82%	20.19%	191.52%	-37.33%
Enterprise Value	97	91	72	139	106	40
Last Close Price	3.42	3.50	3.16	5.60	4.77	2.06
PS Ratio	-	-	467.53	-	279.02	-
PB Ratio	6.76	5.96	4.20	6.09	4.11	5.93
P/TBV Ratio	6.78	5.63	4.03	5.91	4.03	5.59
EV/Sales Ratio	-	-	342.38	-	206.32	-
Debt / Equity Ratio	0.01	0.01	0.01	0.01	0.01	0.01
Asset Turnover	-	-	0.01	-	0.02	-
Quick Ratio	7.76	8.04	11.89	14.60	28.13	7.62
Current Ratio	8.45	8.55	12.50	14.83	28.35	7.88
Return on Equity (ROE)	-62.15%	-60.10%	-38.51%	-43.74%	-61.02%	-154.36%
Return on Assets (ROA)	-36.95%	-36.70%	-24.61%	-26.02%	-35.92%	-81.88%
Return on Capital (ROIC)	-41.00%	-40.52%	-26.48%	-27.34%	-37.88%	-98.19%
Return on Capital Employed (ROCE)	-76.90%	-72.40%	-46.90%	-48.90%	-37.50%	-124.80%
Earnings Yield	-9.87%	-11.15%	-9.99%	-7.92%	-9.07%	-20.44%
FCF Yield	-6.08%	-6.51%	-6.32%	-3.78%	-3.46%	-12.63%
Buyback Yield / Dilution	-2.02%	-2.96%	-1.99%	-6.28%	-28.57%	-12.33%

Updated Sep 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q